Form 4: Premier, Inc. CEO Michael Alkire Sells Shares Under 10b5-1 Trading Plan

Premier, Inc. CEO Michael Alkire sold 17,375 shares of Class A Common Stock at an average price of $20.13 on July 24, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On July 24, 2024, Michael J. Alkire, President and CEO of Premier, Inc., sold 17,375 shares of Class A Common Stock.
• The sale was executed at a weighted average price of $20.13 per share, with individual prices ranging from $20.00 to $20.21.
• The transaction was conducted under a Rule 10b5-1 trading plan adopted on February 23, 2024.
• Following the transaction, Alkire directly owns 562,698 shares of Premier, Inc. Class A Common Stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting an insider stock sale under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transaction.

Industry Context

Insider sales are a common occurrence, and the use of a 10b5-1 trading plan suggests the sale was pre-planned and not based on current insider information. Investors often monitor insider transactions for signals about a company's prospects, but sales under 10b5-1 plans are generally viewed as less informative.

Comparison to Industry Standards

• Comparing Alkire's transactions to other healthcare company executives' trading activity would provide context.
• For example, if other CEOs in similar companies like McKesson or Cardinal Health are also selling shares under 10b5-1 plans, it might indicate a broader trend or sector-specific consideration.
• Without this comparative data, it's difficult to assess whether Alkire's actions are typical or unusual.

Stakeholder Impact

• The stock sale could have a minor impact on shareholder sentiment, although the use of a 10b5-1 plan mitigates concerns about insider information.
• The transaction does not appear to directly affect employees, customers, suppliers, or creditors.

Key Dates